Treatment of hyperadrenocorticism in dogs: a survey of internists and dermatologists.
Behrend
E N
EN
Department of Anatomy, Physiology and Pharmacology, College of Veterinary Medicine, Auburn University, AL 36849, USA.
Kemppainen
R J
RJ
Clark
T P
TP
Salman
M D
MD
Peterson
M E
ME
D000306:Adrenal Cortex Neoplasms / Q000150:complications / Q000662:veterinary; D000315:Adrenalectomy / Q000662:veterinary; D000308:Adrenocortical Hyperfunction / Q000209:etiology / Q000628:therapy / Q000662:veterinary*; D000324:Adrenocorticotropic Hormone; D000818:Animals; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D004283:Dog Diseases / Q000209:etiology / Q000628:therapy*; D004285:Dogs; D005938:Glucocorticoids / Q000627:therapeutic use; D007654:Ketoconazole / Q000627:therapeutic use; D008939:Mitotane / Q000627:therapeutic use; D010911:Pituitary Neoplasms / Q000150:complications / Q000662:veterinary; D011241:Prednisone / Q000627:therapeutic use; D011795:Surveys and Questionnaires
D018931:Antineoplastic Agents, Hormonal; D005938:Glucocorticoids; D008939:Mitotane; D000324:Adrenocorticotropic Hormone; D007654:Ketoconazole; D011241:Prednisone